Testicular cancer: The quest continues

Research output: Contribution to journalReview articlepeer-review

94 Scopus citations


Treatment for testicular cancer has dramatically improved during the last 15 years. Much of this success has come about because of improved staging and operative techniques but, most importantly, through the introduction of successful systemic chemotherapy. Nonetheless, relevant issues still remain to be addressed in regard to the optimal therapy for patients with germ cell neoplasms. Included in these issues is delineating the most effective but minimally morbid treatment for patients with early-stage and low-volume metastatic disease while continuing to create innovative treatment approaches for poor-risk patients with metastatic disease. The unique association of primary mediastinal germ cell neoplasms with the development of non-germ cell cancers and Klinefelter's syndrome may provide some early clues for the determination of factors controlling differentiation. These observations issue a challenge to both clinical and preclinical researchers involved in the study of this neoplasm. [J Natl Cancer Inst 1988;80:1373-1382].

Original languageEnglish (US)
Pages (from-to)1373-1382
Number of pages10
JournalJournal of the National Cancer Institute
Issue number17
StatePublished - Feb 2 1988

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Testicular cancer: The quest continues'. Together they form a unique fingerprint.

Cite this